Pulse Explore Journal Club Debates Trending Researchers

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Home Explore Journal Club Trending

⌘+K

Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease | Synapse

May 25, 2006

View Full Paper

Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease

Olle RingdénUniversité Claude Bernard Lyon 1 MUMehmet UzunelUnisys (United States)IRIda RasmussonUppsala University

Key Points

Key points are not available for this paper at this time.

Abstract

MSC is a very promising treatment for severe steroid-resistant acute GVHD.

Ask AI

Helpful

Bookmark

Share

View Full Paper

Ask AI

Helpful

Bookmark

Share

View Full Paper

Cite This Study

Ringdén et al. (Thu,) studied this question.

synapsesocial.com/papers/69dcb33398c6111533e5379a https://doi.org/https://doi.org/10.1097/01.tp.0000214462.63943.14

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Immunobiology of Human Mesenchymal Stem Cells and Future Use in Hematopoietic Stem Cell Transplantation2005 · 482 citations
2Fetal Mesenchymal Stem-Cell Engraftment in Bone after In Utero Transplantation in a Patient with Severe Osteogenesis Imperfecta2005 · 452 citations
3Human and animal mesenchymal progenitor cells from bone marrow: Identification of serum for optimal selection and proliferation1996 · 286 citations
4Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings.1995 · 181 citations
5HETEROTOPIC TRANSPLANTS OF BONE MARROW1968 · 1,685 citations